Content starts here
CLOSE ×
Search
 
Aug 12, 2022
AARP: House Vote on Prescription Drugs will Bring Real Relief to Seniors’ Pocketbooks
Allowing Medicare to Negotiate Lower Drug Prices is a Major Victory for Older Americans

En español | WASHINGTONAARP issued the following statement from Jo Ann Jenkins, AARP Chief Executive Officer, following the House passage of the Inflation Reduction Act of 2022:

“Today is a momentous day for older Americans. By passing the Inflation Reduction Act, Congress has made good on decades of promises to lower the price of prescription drugs. Seniors should never have to choose between paying for needed medicine or other necessities like food or rent, and tens of millions of adults in Medicare drug plans will soon have peace of mind knowing their out-of-pocket expenses are limited every year.

“Many people said this couldn’t be done, but AARP isn’t afraid of a hard fight. We kept up the pressure, and now, for the first time, Medicare will be able to negotiate with drug companies for lower prices, saving seniors money on their medications.

“I thank the House members whose votes today will bring real relief to millions of Americans, and I look forward to President Biden signing this bill into law.”

###

About AARP
AARP is the nation’s largest nonprofit, nonpartisan organization dedicated to empowering people 50 and older to choose how they live as they age. With a nationwide presence and nearly 38 million members, AARP strengthens communities and advocates for what matters most to families: health security, financial stability and personal fulfillment. AARP also produces the nation's largest circulation publications: AARP The Magazine and AARP Bulletin. To learn more, visit www.aarp.orgwww.aarp.org/espanol or follow @AARP, @AARPenEspanol and @AARPadvocates, @AliadosAdelante on social media.

For further information: Amanda Davis, 202-434-2560, media@aarp.org, @AARPMedia